The immune escape in melanoma: role of the impaired dendritic cell function
Authors:
- Marco TucciMTMarco Tucci
- Stefania StucciSSStefania Stucci
- Anna PassarelliAPAnna Passarelli
- Giuseppe GiudiceGGGiuseppe Giudice
- Franco DammaccoFDFranco Dammacco
- Franco SilvestrisFSFranco Silvestris
- 26 August 2014
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 10 (10) , 1395-1404
Abstract
Melanoma is an immunogenic cancer that overcomes the control of the immune system through the production of tolerogenic cytokines and growth factors in the microenvironment. In melanoma, dendritic cells (DC) show severe alterations in maturation, cross-priming and antigenic presentation, while other accessory cells infiltrating the tumor milieu also suppress DCs through the activation of the STAT pathway by IL-10 and IL-6. Novel immunotherapy strategies blocking cytotoxic T-lymphocyte antigen (CTLA-4) are successful in advanced disease, while melanoma cells carrying the BRAF(V600E) mutation further reinforce the immune suppression by activating MAPKs. Here, we review the major mechanisms involved in the cross-talk between melanoma cells and the immune system as well as the issue of defects in DCs in relation to novel studies aimed at restoring their anti-tumor activity.Keywords
This publication has 79 references indexed in Scilit:
- Origin and development of dendritic cellsImmunological Reviews, 2010
- Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variantEuropean Journal of Cancer, 2009
- Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies?Cancer and Metastasis Reviews, 2006
- Enhancement of clonogenicity of human multiple myeloma by dendritic cellsJournal of Experimental Medicine, 2006
- Quantitative and functional defects of dendritic cells in classic Kaposi's sarcomaClinical Immunology, 2006
- HUMAN T CELL RESPONSES AGAINST MELANOMAAnnual Review of Immunology, 2006
- Expression of melanoma-associated antigens in melanoma cell culturesExperimental Dermatology, 2005
- Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administrationSeminars in Cancer Biology, 2003
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- Dendritic cells and the control of immunityNature, 1998